Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Clinical trial NCT02503358 · COMPLETED
Trial details
- NCT number
- NCT02503358
- Sponsor
- OHSU Knight Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-21
- Primary completion
- 2020-07-16
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.